CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −3,011 | $4.48 | $13K | 309,057 |
| 2021-06-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −3,054 | 6,108 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,527 | 200,343 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,527 | 201,870 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise | +3,054 | 204,924 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −3,011 | $4.48 | $13K | 201,913 |
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −3,054 | 6,108 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,527 | 447,725 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,527 | 449,252 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,054 | 452,306 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −3,127 | $4.48 | $14K | 449,179 |
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,527 | 3,054 | ||
| 2021-06-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,054 | 6,108 | ||
| 2021-06-30 | Kennedy Joseph T General Counsel | Option exercise | +1,805 | 312,831 | ||
| 2021-06-30 | Kennedy Joseph T General Counsel | Option exercise | +1,805 | 314,636 |
Page 26 of 67 · 1,339 trades